Type:Notice
Citation:86 FR 4081
Reading Time:about a minute or two
The Food and Drug Administration (FDA) is withdrawing the approval of 27 abbreviated new drug applications because the companies that made these drugs told the FDA that they are no longer selling them. The withdrawal means these drugs will no longer have permission to be sold in the market. This action will take effect on February 16, 2021, but any remaining drug inventory that is still compliant with regulations can be used up until it runs out or expires.
Simple Explanation
The FDA is taking back its permission for 27 kinds of medicines because the companies who made them said they aren't selling them anymore, and starting February 16, 2021, these medicines can't be sold.